Autoantibody of NRIP, a novel AChR-interacting protein, plays a detrimental role in myasthenia gravis.

J Cachexia Sarcopenia Muscle · 2021 · PMC8200423 · PMID 33773096

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceP = 0.077so close (0.05 < p ≤ 0.1)

showed a trendno p-value reported

Patients with MG and anti‐NRIP autoantibody showed a trend to have unstable MG course (requiring titration of MG‐specific medication within 1 year) compared with those without anti‐NRIP autoantibodies, although the difference did not reach statistical significance ( P = 0.077).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.